Syringic acid, a novel natural phenolic acid, normalizes hyperglycemia with special reference to glycoprotein components in experimental diabetic rats
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
To evaluate the antidiabetic effect of syringic acid, a natural phenolic compound on the levels of glycoprotein components in plasma and tissues of alloxan induced diabetic rats. Diabetes was induced in male Wistar rats by a single intraperitoneal injection of alloxan (150 mg/kg b.w). Syringic acid (50 mg/kg b.w) was administered orally for 30 d. The effects of syringic acid on plasma glucose, insulin, C-peptide, plasma and tissue glycoproteins were studied. Oral administration of syringic acid (50 mg/kg b.w) for 30 d positively modulates the glycemic status in alloxan induced diabetic rats. The levels of plasma glucose were decreased with significant increase of plasma insulin and C-peptide level. The altered levels of plasma and tissue glycoprotein components were restored to near normal. No significant changes were noticed in normal rats treated with syringic acid. The present findings suggest that syringic acid can potentially ameliorate glycoprotein components abnormalities in addition to its antidiabetic effect in experimental diabetes, further clinical studies are required to evaluate the use of syringic acid as an effective therapeutic agent for the treatment of diabetes mellitus.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diabetes in Asia: Epidemiology, Risk Factors, and Pathophysiology
Chan, J. C. N., Malik, V., Jia, W., Kadowaki, T., Yajnik, C. S., Yoon, K.-H., & Hu, F. B. (2009) · JAMA · doi:10.1001/jama.2009.726 · Cited by 1,997
Diabetes and mitochondrial function: Role of hyperglycemia and oxidative stress
Rolo, A. P., & Palmeira, C. M. (2006) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2006.01.003 · Cited by 1,007 · cited 1×
“Elevated blood glucose induced microvascular and macrovascular changes, such as atherosclerosis, retinopathy, nephropathy, coronary artery disease, cerebral vascular disease, and peripheral artery disease[3], the reasons for injury related to hyperglycemia is increased polyol pathway flux, increased glycation of prote…”
BackgroundThe Role of Advanced Glycation End Products in Progression and Complications of Diabetes
Goh, S.-Y., & Cooper, M. E. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1817 · Cited by 987 · cited 1×
“Stimulation of kidney protein synthesis may contribute to explain the increase in the synthesis of glycoproteins as well as the renal hypertrophy that occurs early in diabetes[27].”
BackgroundBalamurugan, R., Duraipandiyan, V., & Ignacimuthu, S. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.05.025 · Cited by 173 · cited 1×
“Elevated blood glucose induced microvascular and macrovascular changes, such as atherosclerosis, retinopathy, nephropathy, coronary artery disease, cerebral vascular disease, and peripheral artery disease[3], the reasons for injury related to hyperglycemia is increased polyol pathway flux, increased glycation of prote…”
Background
Research works printed but not linked: 28
- Whiting, 2011, IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030, Diabetes Res Clin Pract, 94, 311, 10.1016/j.diabres.2011.10.029 · DOI · Paper page
- Mittal, 1996, Changes in tubular membrane glycosylation in diabetic insulin and thyroxin treated rat kidneys, Ind J Exp Biol, 34, 782
- Peppa, 2009, Advanced glycoxidation products and impaired diabetic wound healing, Wound Repair Regen, 17, 461, 10.1111/j.1524-475X.2009.00518.x · DOI · Paper page
- Pari, 2010, Protective role of coumarin on plasma and tissue glycoprotein components in streptozotocin-nicotinamide induced hyperglycemic rats, Int J Biol Med Res, 1, 61
- Wangchuka, 2011, Evaluation of an ethnopharmacologically selected Bhutanese medicinal plants for their major classes of phytochemicals and biological activities, J Ethnopharmacol, 137, 730, 10.1016/j.jep.2011.06.032 · DOI
- Nadeem, 2011, Ameliorative effects of Alpinia calcarata Roscoe in alloxan-induced diabetic rats, Dig J Nanomater Bios, 6, 991
- Niebes, 1972, Determination of enzymes and degradation products of glycosaminoglycan metabolism in the serum of healthy and varicose subjects, Clin Chim Acta, 42, 399, 10.1016/0009-8981(72)90105-2 · DOI · Paper page
- Warren, 1959, The thiobarbituric acid assay of sialic acids, J Biol Chem, 234, 1971, 10.1016/S0021-9258(18)69851-5 · DOI · Paper page
- Wagner, 1979, A more sensitive assay discriminating galactosamine and glucosamine in mixtures, Anal Biochem, 94, 394, 10.1016/0003-2697(79)90379-8 · DOI · Paper page
- Dische, 1948, A specific color reaction of methylpentoses and a spectrophotometric micro method for their determination, J Biol Chem, 175, 595, 10.1016/S0021-9258(18)57178-7 · DOI · Paper page
- Duncan, 1957, Multiple ranges tests for correlated and heteroscedastic means, Biometrics, 13, 359, 10.2307/2527799 · DOI · Paper page
- Szkudelski, 2001, The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas, Physiol Res, 50, 537, 10.33549/physiolres.930111 · DOI · Paper page
- Pari, 2009, Efficacy of coumarin on hepatic key enzymes of glucose metabolism in chemical induced type 2 diabetic rats, Chem Biol Interact, 181, 292, 10.1016/j.cbi.2009.07.018 · DOI
- Wang, 2012, Persistence of prolonged C-peptide production in type 1 diabetes as measured with an ultrasensitive C peptide assay, Diabetes Care, 35, 465, 10.2337/dc11-1236 · DOI · Paper page
- Wahren, 2004, C-peptide: new findings and therapeutic implications in diabetes, Clin Physiol Funct Imaging, 24, 180, 10.1111/j.1475-097X.2004.00558.x · DOI
- Brownlee, 2001, Biochemistry and molecular cell biology of diabetic complications, Nature, 414, 813, 10.1038/414813a · DOI · Paper page
- Saravananan, 2010, Antidiabetic effect of S allylcysteine: Effect on plasma and tissue glycoproteins in experimental diabetes, Phytomedicine, 17, 1086, 10.1016/j.phymed.2010.04.008 · DOI
- Pari, 2010, Preventive effect of diosmin, a bioflavonoid, on glycoprotein changes in streptozotocin-nicotinamide-induced type 2 diabetic rats, In J Pharm Sci Res, 10, 89
- Sundaram, 2012, Antihyperglycemic effect of iridoid glucoside, isolated from the leaves of Vitex negundo in streptozotocin-induced diabetic rats with special reference to glycoprotein components, Phytomedicine, 19, 211, 10.1016/j.phymed.2011.10.006 · DOI
- Shao, 2005, Chronic hyperglycemia enhances PEPCK gene expression and hepatocellular glucose production via elevated liver activating protein/liver inhibitory protein ratio, Diabetes, 54, 976, 10.2337/diabetes.54.4.976 · DOI · Paper page
- Shah, 2009, Therapeutic strategies in the treatment of diabetic nephropathy-a translational medicine approach, Curr Med Chem, 16, 997, 10.2174/092986709787581897 · DOI
- Kikkawa, 2003, Progression of diabetic nephropathy, Am J Kidney Dis, 41, 19, 10.1053/ajkd.2003.50077 · DOI · Paper page
- Spiro, 1971, Effect of diabetes on the biosynthesis of the renal glomerular basement membrane. Studies on the glycosyl transferase, Diabetes, 20, 641, 10.2337/diab.20.10.641 · DOI
- Buse, 2006, Hexosamines, insulin resistance, and the complications of diabetes: current status, Am J Physiol Endocrinol Metab, 290, 1, 10.1152/ajpendo.00329.2005 · DOI · Paper page
- Pari, 2009, Protective role of tetrahydrocurcumin and chlorogenic acid on glycoprotein changes in streptozotocin-nicotinamide-induced diabetic rats, J Pharm Sci Res, 1, 173
- Ramkumar, 2007, Ethanol extract of Gymnema montanum leaves reduces glycoprotein components in experimental diabetes, Nutr Res, 27, 97, 10.1016/j.nutres.2006.12.010 · DOI
- Ciftci, 2010, Effect of fluoride exposure on serum glycoprotein pattern and sialic acid level in rabbits, Biol Trace Elem Res, 133, 51, 10.1007/s12011-009-8563-y · doi:10.1007/s12011-009-8563-y
- Gavella, 2003, Serum sialic acid in subjects with impaired glucose tolerance and in newly diagnosed type 2 diabetic patients, Acta Diabetol, 40, 95, 10.1007/s005920300012 · doi:10.1007/s005920300012
Cited by
Srinivasulu, C., Ramgopal, M., Ramanjaneyulu, G., Anuradha, C. M., & Suresh Kumar, C. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.09.069 · Cited by 611
Bioactive compounds in banana and their associated health benefits – A review
Singh, B., Singh, J. P., Kaur, A., & Singh, N. (2016) · Food Chemistry · doi:10.1016/j.foodchem.2016.03.033 · Cited by 531
Phenolic acids from vegetables: A review on processing stability and health benefits
Rashmi, H. B., & Negi, P. S. (2020) · Food Research International · doi:10.1016/j.foodres.2020.109298 · Cited by 465
Vinayagam, R., Jayachandran, M., & Xu, B. (2016) · Phytotherapy Research · doi:10.1002/ptr.5528 · Cited by 267
A Comprehensive Review on Nutritional Value, Medicinal Uses, and Processing of Banana
Ranjha, M. M. A. N., Irfan, S., Nadeem, M., & Mahmood, S. (2022) · Food Reviews International · doi:10.1080/87559129.2020.1725890 · Cited by 176
Metadata
- Authors
- Muthukumaran, J., Srinivasan, S., Venkatesan, R. S., Ramachandran, V., & Muruganathan, U.
- Venue
- Journal of Acute Disease
- Published
- 2013
- Volume
- 2
- Issue
- 4
- Pages
- 304-309
- ISSN
- 2221-6189 (ISSN-L)
- OpenAlex
- W1991025907
- Cited by
- 122
- References
- 4
- FWCI
- 2.59
- Type
- journal article
- Language
- en
- Open access
- diamond
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0/ (vor, 751 d)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Syringic acid, a novel natural phenolic acid, normalizes hyperglycemia with special reference to glycoprotein components in experimental diabetic rats. https://app.cochat.ai/papers/10.1016/s2221-6189(13)60149-3
- The paper
- Muthukumaran, J., Srinivasan, S., Venkatesan, R. S., Ramachandran, V., & Muruganathan, U. (2013). Syringic acid, a novel natural phenolic acid, normalizes hyperglycemia with special reference to glycoprotein components in experimental diabetic rats. Journal of Acute Disease. https://doi.org/10.1016/s2221-6189(13)60149-3
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.